Dr.
Rahul Kumar
Male
Affiliation
Medical Officer
Department of
EHS
Dr.
Rajendra Kumar
Male
Affiliation
Chief Medical Officer ( SAG)
Department of
EHS
Dr.
Pranay Kumar Sinha
Male
Affiliation
Chief Medical Officer ( SAG)
Department of
EHS
Dr.
Prasanna Vijay Kumar
Male
Affiliation
Chief Medical Officer & Officer I/c
Department of
EHS
Dr.
Govind K. Makhariya
Male
Affiliation
Prof. I/c EHS
Department of
EHS
Dr.
Nirupam Madaan
Male
Affiliation
Medical Supdt.
Department of
EHS
Dr.
Ajay Godwin Potnuri
Male
M.S (Pharm), Ph.D.
Affiliation
Scientist
Department of
Pharmacology
National Poisons Information Centre
Contact
Email :
dr[dot]ajaygodwin[dot]p[at]gmail[dot]com
Phone :
011-26593677
Office Address
4th Floor, Department of Pharmacology, Teaching Block, All India Institute of Medical Sciences (AIIMS), New Delhi 110029
Area of Interest:
Cardiovascular Pharmacology and toxicology with a special emphasis on hypertensive heart disease and vascular biology
Education:
- B.Pharmacy from Andhra University, Visakhapatnam
- M.S (Pharm) in Pharmacology and Toxicology from National Institute of Pharmaceutical Education and Research, Guwahati
- Ph.D in Biological Sciences from Sree Chitra Tirunal Institute for Medical Sciences and Technology,Thriuvananthapuram
- ICMR PDF from ICMR NARFBR, Turkapally, Shamirpet, Hyderabad
Research Interest/ area:
Cardiovascular Pharmacology and toxicology with a special emphasis on hypertensive heart disease and vascular biology
Past Position:
Assistant Research Officer (Pharmacology) at National Ayurveda Research Institute for Panchakarma, Cheruthuruthy, Thrissur, Kerala (Jan’ 2021 – Sep’ 2022)
Ongoing Projects:
- Evaluation of Guduchi Sattva for its anti-platelet and thrombolytic potential using in-vitro and in-vivo experimental models, funded by Indian Council for Medical Research. [Budget:15,90,000]
Completed Projects:
- Acute and 90 days Toxicity profiling of AYUSH 64, funded by Central Council for Research in Ayurvedic Sciences. [Budget:18,97,450]
- Understanding the role of FFAR2 In Modulating atherosclerosis in WNIN/Ob rat, funded by Indian Council for Medical Research. [Budget:21,60,000]
Selected Publications:
- Potnuri AG, Allakonda L, Appavoo A, Saheera S, Nair RR. Targeting histamine-2 receptor for prevention of cardiac remodeling in chronic pressure overload. Int J Card. 2016;202:831-833.
- Kondru SK, Potnuri AG, Allakonda L, Konduri P. Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model. Molecular and Cellular Biochemistry. 2018;1-12.
- Sudam VS, Potnuri AG, Subhashini NJP. Syk–GTP RAC-1 mediated immune-stimulatory effect of Cuscuta epithymum, Ipomoea batata, and Euphorbia hirta plant extracts. Biomedicine & Pharmacotherapy. 2018;96:742-749.
- Saheera S, Potnuri AG, Nair RR. Modulation of cardiac stem cell characteristics by metoprolol in hypertensive heart disease. Hypertension Research. 2018 Feb 15. doi:10.1038/s41440-018-0015-7.
- Saheera S, Potnuri AG, Nair RR. Histamine-2 receptor antagonist Famotidine modulates cardiac stem cell characteristics in hypertensive heart disease. PeerJ. 2017 Oct 9;5:e3882. doi:10.7717/peerj.3882.
- Potnuri AG, Allakonda L, Lahkar M. Crocin attenuates cyclophosphamide-induced testicular toxicity by preserving glutathione redox system. Biomedicine & Pharmacotherapy. 2018;101:174-180.
- Potnuri AG, Allakonda L, Appavoo A, Saheera S, Nair RR. Association of histamine with hypertension-induced cardiac remodeling and reduction of hypertrophy with histamine-2 receptor antagonist famotidine in comparison with beta-blocker metoprolol. Hypertension Research. 2018.
- Saheera S, Potnuri AG, Nair RR. Protective effect of antioxidant Tempol on cardiac stem cells in chronic pressure overload hypertrophy. Life Sciences. 2019;222:88-93.
- Potnuri AG, Allakonda L, Saheera S. Involvement of histamine-2 receptor in Alpha-1 adrenoceptor-mediated cardiac hypertrophy and oxidative stress in H9c2 cardiomyoblasts. J Cardiovasc Transl Res. 2021 Feb;14(1):184-194.
- Allakonda L, Kakaraparthi A, Potnuri AG. Beta-1 adrenoceptor blockade promotes angiogenesis in hypertrophied myocardium of TAC rat. Clinical and Experimental Pharmacology and Physiology. 2021;48(1):121-128.
Dr.
Devendra Singh
Male
Pharm (Pharmacology Toxicology and Therapeutics) , Ph.D. (Pharmacology)
Affiliation
Scientist
Department of
Pharmacology
National Poisons Information Centre
Contact
Email :
dvndr[dot]singh[at]gmail[dot]com
Phone :
011-26593677
26589391
Awards
- Qualified GATE 2009
- Qualified GPAT 2010, 2012 and 2013
Area of Interest:
Neuropharmacology, Ischemic Stroke, Alzheimer’s Disease, Preclinical research
List of Publications:
- Joshi B*, Singh D*, Wasan H, Sharma U, Dinda AK, Reeta Kh. Tideglusib ameliorates ischemia/reperfusion damage by inhibiting GSK-3β and apoptosis in rat model of ischemic stroke. J. Stroke Cerebrovasc. Dis. 2022 Apr;31(4):106349. (IF-2.677) (* equal first authorship)
- Wasan H*, Singh D*, Joshi B, Deept Upadhyay, Sharma U, Dinda AK, Reeta Kh. Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex. Neur. Res. 2021 Dec 9;1-12. doi:10.1080/01616412.2021.1997010. (IF-2.529) (* equal first authorship)
- Wasan H, Singh D, Joshi B, Sharma U, Dinda AK, Reeta Kh. Post stroke safinamide treatment attenuates neurological damage by modulating autophagy and apoptosis in experimental model of stroke in rats. Mol. Neurob. 2021 Aug 28. doi:10.1007/s12035-021-02523-6. (IF-5.682)
- Singh D, Wasan H, Reeta KH. Preclinical Stroke Research and Translational Failure: A Bird’s Eye View on Preventable Variables. Cell. Mol. Neurobiol. 2021. doi:10.1007/s10571-021-01083-6. (IF-4.231)
- Wasan H, Singh D, Kh R. Safinamide in neurological disorders and beyond: evidence from preclinical and clinical studies. Brain Res. Bull. 2020 Dec 30: S0361-9230(20)30735-8. (IF-3.715)
- Verma V*, Singh D*, Reeta KH. Sinapic acid alleviates oxidative stress and neuroinflammatory changes in sporadic model of Alzheimer’s disease in rats. Brain Sciences, 2020 Nov;10(12):923. (IF-3.333) (* equal first authorship)
- Singh D, Wasan H, Reeta KH. Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications. Free Radic. Biol. Med. 2020 Oct 19;161:263-271. (IF-8.101)
- Singh D, Wasan H, Mathur A, Gupta YK. Indian perspective of remdesivir: A promising COVID-19 drug. Indian J. Pharmacol. 2020 May-Jun;52(3):227-228. (IF-2.833)
- Singh D, Reeta KH, Sharma U, Jagannathan NR, Dinda AK, Gupta YK. Neuro-protective effect of monomethyl fumarate on ischemia reperfusion injury in rats: Role of Nrf2-HO1 pathway in peri-infarct region. Neurochem. Int. 2019 June;126:96-108. (IF-4.297)
- Reeta KH, Singh D, Gupta YK. Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions, and neuroinflammation. Neurochem. Int. 2017 Sep;108:146-156. (IF-4.297)
Dr.
SUNDER S SAMUEL
Male
M.Sc. , PhD
Affiliation
Scientist
Department of
Pharmacology
National Poisons Information Centre
Contact
Email :
sunder_sam[at]yahoo[dot]co[dot]uk
Phone :
011-26593677
26589391
Area of Interest:
Cardio & neurotoxicology
Research Interest/ area
Toxicology
Dr.
Subodh Kumar
Male
Affiliation
Additional Professor
Department of
Transport Facility
